Operating Expenses: The sum of all operating expenses for the given industry.
ReShape Lifesciences Inc. (RSLS) had Operating Expenses of $24.06M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$8.68M |
|
$-11.39M |
|
$3.13M |
|
$5.55M |
|
|
Operating Expenses |
$24.06M |
$-15.38M |
|
$4.05M |
|
$-11.34M |
|
$-11.34M |
|
$-11.39M |
|
$-11.39M |
|
$-11.39M |
|
$-11.39M |
|
$-15.38M |
|
$-15.23M |
|
0.10M |
|
0.10M |
|
$-111.05 |
|
$-111.05 |
|
| Balance Sheet Financials | |
$10.30M |
|
$0.06M |
|
$0.37M |
|
$10.66M |
|
$3.78M |
|
-- |
|
$0.22M |
|
$4.00M |
|
$6.66M |
|
$6.66M |
|
$6.66M |
|
0.40M |
|
| Cash Flow Statement Financials | |
$-16.96M |
|
$-0.01M |
|
$17.57M |
|
$3.96M |
|
$4.56M |
|
$0.60M |
|
$0.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
63.93% |
|
-177.26% |
|
-177.26% |
|
-175.49% |
|
-130.62% |
|
-131.22% |
|
$-16.97M |
|
-- |
|
-- |
|
-- |
|
0.81 |
|
0.84 |
|
5.23 |
|
69.78 |
|
-170.90% |
|
-170.90% |
|
-106.79% |
|
-170.90% |
|
$16.51 |
|
$-165.62 |
|
$-165.53 |
|